ALPS Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

ALPS Advisors’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,755	Closed	-$490K	–	1052
2018 Q2	$490K	Sell	12,755 -600	-4%	-$20.2K	﹤0.01%	592
2018 Q1	$450K	Buy	13,355 +4,024	+43%	+$154K	﹤0.01%	716
2017 Q4	$414K	Hold	9,331	–	–	﹤0.01%	674
2017 Q3	$467K	Buy	+9,331	New	+$477K	﹤0.01%	635
2016 Q3	–	Sell	-7,697	Closed	-$426K	–	744
2016 Q2	$426K	Sell	7,697 -568	-7%	-$31.3K	﹤0.01%	386
2016 Q1	$441K	Sell	8,265 -2,464	-23%	-$121K	﹤0.01%	414
2015 Q4	$552K	Hold	10,729	–	–	0.01%	329
2015 Q3	$4.84K	Sell	10,729 -2,116	-16%	-$100K	0.01%	457
2015 Q2	$594K	Buy	12,845 +200	+2%	+$8.75K	0.01%	302
2015 Q1	$542K	Buy	+12,645	New	+$482K	﹤0.01%	325

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

ALPS Advisors's PBH Position: Q3 2018 in Review

ALPS Advisors sold out of Prestige Consumer Healthcare (PBH) in Q3 2018, closing a stake of 12,755 shares — an estimated $490K sold.

ALPS Advisors first reported a position in PBH in Q1 2015 and held it in 10 quarters. The position peaked at $594K in Q2 2015. 237 funds tracked by Wall St. Rank hold PBH as of Q3 2018.

ALPS Advisors reported no remaining Prestige Consumer Healthcare position as of Q3 2018 after selling out during the quarter.
ALPS Advisors sold 12,755 Prestige Consumer Healthcare shares in Q3 2018, an estimated $490K.
ALPS Advisors first reported a position in Prestige Consumer Healthcare in Q1 2015 and held it in 10 quarters.
ALPS Advisors's Prestige Consumer Healthcare position peaked at $594K in Q2 2015.
237 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2018.

Based on ALPS Advisors's 13F filing for Q3 2018, filed 25 Oct 2018.